Redefining Omalizumab Discontinuation in Chronic Spontaneous Urticaria: The Value of Optimization and Predictive Factors of Relapse. A 52-Week Multicenter Study J. Ceravalls, A.M. Giménez-Arnau, V. Expósito-Serrano, N. Fernández Chico, A. Lara Moya, I. Bielsa, P. Ribó, B. Mascaró-Hereza, M. Bonfill-Ortí, J. Spertino, E. Serra, C. Baliu-Piqué, G. Melé-Ninot

The Role of Adjuvant Therapy in the Management of Chronic Urticaria W. Keumala Budianti, S. Mahri, D. Almira

Erythema, Localized Edema and Heat vs Forearm Perimeter Increase. Time to Revise the Consensus Recommendations on the Vortex Provocation Test in Vibratory Urticaria–Angioedema? M.E. Gatica-Ortega, B. Sánchez-Albisua, D.M. Arranz-Sánchez, B. Pérez-Tato, A. Sánchez-Gilo, S. Córdoba-Guijarro, F.J. Ortiz-Frutos, N. Hernández-Cano, E. Gómez de la Fuente, M. Elosua-González, M. Bergón-Sendín, C. García-Martín, T. Sanz-Sánchez, O. Mazuela-Díez, R. Torres-Aranda, L. Vergara-de-la-Campa, S. Marinero-Escobedo, A. Alegre-Bailo, A. Garrido-Ríos, F. Tous-Romero, J.M. Busto-Leis, C. Sarró-Fuente, F.J. Rodríguez-Cuadrado, P. García-Piqueras, P. Beneyto, M.A. Pastor-Nieto